The technology, which is still in the research and development phase, allows for “for more precise 3D visualization of different tissues and contrast agents by capturing X-rays at multiple energy levels simultaneously,” according to a Feb. 25 news release from the university.
“This could improve cancer detection,” study author Mini Das, PhD, a professor at the University of Houston, said in the release. “If you inject two different contrast agents — one targeting a tumor and another targeting inflammation — you could see where each one accumulates.”
Read the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
